UNITED THERAPEUTICS Corp (NASDAQ:UTHR)

US · Delayed Price · Currency is USD

Healthcare · Biotechnology

Full ChartAlerts Compare

591.13+3.63 (+0.62%)

Market cap

$25.4B

Analyst consensus

Buy

Listed since

Jun 17, 1999

Website

unither.com

Insider Score

––Not scored

UTHR Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

See stocks that are scored

Company News & Press Releases

No press releases on file for UTHR.

Our Coverage

InsiderBuyingOur analysisUnited Therapeutics CEO Martine Rothblatt Sold $15.41 Million of Stock in One WeekMartine Rothblatt, CEO of United Therapeutics Corp, recorded $15.41 million in open market sales across 47 Form 4 filings in the seven days through October 8th, 2026. No other insider at the company sold in that window.Oct 13, 2026

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.